ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 106995 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 106995; 2) Community: the network communities that were significantly associated with the response to NSC 106995; 3) Molecule: the relationships between components within communities and NSC 106995; 4) MDR: the compounds that were significantly associated with the NSC 106995.

NSC Compound Enrichment Correlation
NSC 664161 Null 0.000337881418217048 0.059141481
NSC 683402 Null 0.000337881418217048 0.11715416
NSC 707148 Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-.beta.-D-galacto pyranosyl)oxy]-14-hydroxy-, (3.beta.,5.beta)- (9CI) 0.000337881418217048 0.17892756
NSC 707149 Card-20(22)-enolide, 16-(acetyloxy)-3-[(6-deoxy-3-O-methyl- .beta.-D-galactopyranosyl)oxy]-14-hydroxy-,(3.beta.,5.beta.,16.beta.)- (9CI) 0.000337881418217048 0.15127484
NSC 744450 Null 0.000337881418217048 -0.17506876
NSC 726444 4,11-bis[[2-(methylamino)ethyl]amino]-3-[(dimethylamino)meth yl]-1H-naphtho[2,3-f]indole-5,10-dione 0.000345122105154215 0.28758213
NSC 716040 Null 0.000594679750718321 0.18577194
NSC 207895 Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide 0.000613547200832843 0.33710514
NSC 673452 Null 0.000613547200832843 0.3295074
NSC 710548 Null 0.000613547200832843 0.08892431
Total:57  Current:1    [First] [Prev] [Next] [Last]